NovaBridge Biosciences (NBP) Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Non-Current Assets for 8 consecutive years, with $43.0 million the latest figure, recorded in Q4 2025.

• Quarterly Non-Current Assets rose 19.49% year-over-year to $43.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $162.4 million (down 2.27% YoY) and the FY2025 annual result came in at $43.0 million, up 19.49% from the prior year.
• Non-Current Assets fell to $43.0 million in Q4 2025 per NBP's latest filing, from $44.6 million in the prior quarter.
• Over the last five years, Non-Current Assets for NBP reached as high as $209.5 million in Q4 2023 and fell as low as $23.3 million in Q2 2024.
• A 5-year average of $98.1 million and a median of $44.6 million in 2025 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2021 — Non-Current Assets surged 186.85% — and 2024, when it tumbled 82.82%.
• Year by year, Non-Current Assets stood at $188.8 million in 2021, then gained by 6.67% to $201.4 million in 2022, then climbed by 4.01% to $209.5 million in 2023, then slumped by 82.82% to $36.0 million in 2024, then increased by 19.49% to $43.0 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $43.0 million, $44.6 million, and $39.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.